Scientific Advisory Board

Christoph Lengauer, PhD MBA

Partner,
Third Rock Ventures

Howard A. “Skip” Burris III, MD, FASCO, FACP

President & Chief Medical Officer, Sarah Cannon;
Associate, Tennessee Oncology, PLLC

Peter Kiener, PhD

Chief Executive Officer,
Cereius Inc.

Ronald T. Borchardt

Distinguished Professor Emeritus of Pharmaceutical Chemistry,
The University of Kansas-Lawrence

Peter Smith

Chief Early Development Officer,
Alnylam Pharmaceuticals

K. Dane Wittrup, PhD

Professor of Chemical Engineering and Biological Engineering, MIT;
Associate Director, Koch Institute